| ACs | Aminocarbolines |
| AIAs | Aminoimidazoazarenes |
| ATP | Adenosine triphosphate |
| B(a)P | Benzo(a) pyrene |
| CI | Confidence interval |
| CRC | Colorectal cancer |
| CYP1A1 | Aryl-4 monooxigenase |
| CYP450 | Cytochrome P450 |
| DiMeIQx | 2-Amino-3,4,8-trimethylimidazo[4,5-f] quinoxaline |
| EPIC | European Prospective Investigation into Cancer |
| HCAs | Heterocyclic amines |
| IARC | The International Agency for Research on Cancer |
| LAB | Lactic acid bacteria |
| MD | Mediterranean Diet |
| MeIQ | 2-Amino-3,4-dimethylimidazo[4,5-f] quinoline |
| MeIQx | 2-Amino-3,8-dimethylimidazo[4,5-f] quinoxaline |
| MN | Micronucleous assay |
| MTT | (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) |
| NAs | Nitrosamines |
| NOCs | N-Nitroso compounds |
| OECD | Organization for Economic Cooperation and Development |
| PAHs | Polycyclic aromatic hydrocarbons |
| PhIP | 2-Amino-1-methyl-6-phenylimidazo[4,5-b] pyridine |
| ROS | Reactive oxygen species |
| RR | Relative risk |
| SCE | Sister Chromatid Exchange assay |
| SCFA | Short chain fatty acids |
| WD | Western Diet |